News
Experts express alarm that GLP-1 RAs may trigger or worsen eating disorders. But is there any role they might play in binge ...
Both GLP-1 RAs and SGLT2is are associated with a reduced risk for Alzheimer disease and related dementias among people with T2D.
Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related ...
In patients with T2D who had been hospitalized for poorly controlled blood glucose, SGLT2 inhibitors nearly doubled the risk ...
The rising use of GLP-1 agonists to help manage the obesity epidemic is not only reshaping how consumers taking the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results